Eli Lilly to support production of diabetes drugs with USD 450m investment
![Photo: Mike Blake/Reuters/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/14888648/48li33/ALTERNATES/schema-16_9/20200917-222409-4-7741x5164ma.jpg)
Eli Lilly is planning to invest an additional USD 450m to expand its manufacturing capacity located in the Research Triangle in North Carolina.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk to invest EUR 130m in French factory
For subscribers